IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $339,566 | +11318766.7% | 17,995 | +78.2% | 0.06% | – |
Q4 2022 | $3 | -100.0% | 10,100 | -48.2% | 0.00% | – |
Q2 2022 | $7,000 | -56.2% | 19,500 | -41.8% | 0.00% | – |
Q1 2022 | $16,000 | -15.8% | 33,500 | +53.0% | 0.00% | -100.0% |
Q4 2021 | $19,000 | +1800.0% | 21,900 | +20.3% | 0.00% | – |
Q2 2021 | $1,000 | -90.9% | 18,200 | +44.4% | 0.00% | – |
Q4 2020 | $11,000 | +450.0% | 12,600 | -11.9% | 0.00% | – |
Q3 2020 | $2,000 | -80.0% | 14,300 | +31.2% | 0.00% | -100.0% |
Q4 2019 | $10,000 | +900.0% | 10,900 | -94.4% | 0.00% | – |
Q2 2019 | $1,000 | -96.3% | 193,100 | -14.8% | 0.00% | -100.0% |
Q1 2019 | $27,000 | +440.0% | 226,700 | +1273.9% | 0.00% | – |
Q2 2018 | $5,000 | -96.6% | 16,500 | -93.9% | 0.00% | -100.0% |
Q1 2018 | $146,000 | +1522.2% | 270,900 | +439.6% | 0.01% | – |
Q4 2015 | $9,000 | -69.0% | 50,200 | -0.2% | 0.00% | -100.0% |
Q3 2015 | $29,000 | -88.8% | 50,300 | -51.3% | 0.00% | -87.5% |
Q2 2015 | $260,000 | +213.3% | 103,300 | +60.2% | 0.02% | +166.7% |
Q1 2015 | $83,000 | – | 64,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |